awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Triples
Insights
Schema
BETA
Class frequency
Class hierarchy
SPARQL
Graphs
1
Q35794472-08F50BFA-9ADC-455D-AAEB-2744B854602B
Q35794472-08F50BFA-9ADC-455D-AAEB-2744B854602B
BestRank
Statement
http://www.wikidata.org/entity/statement/Q35794472-08F50BFA-9ADC-455D-AAEB-2744B854602B
Cyclophosphamide, thalidomide, and dexamethasone as induction therapy for newly diagnosed multiple myeloma patients destined for autologous stem-cell transplantation: MRC Myeloma IX randomized trial results.
P2860
Q35794472-08F50BFA-9ADC-455D-AAEB-2744B854602B
BestRank
Statement
http://www.wikidata.org/entity/statement/Q35794472-08F50BFA-9ADC-455D-AAEB-2744B854602B
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
0c437f96564d3c2a6a3dc01bcd4a1d5460e6bcd7
P2860
Bortezomib plus dexamethasone is superior to vincristine plus doxorubicin plus dexamethasone as induction treatment prior to autologous stem-cell transplantation in newly diagnosed multiple myeloma: results of the IFM 2005-01 phase III trial.